Chevron – Disclose Costs Related to Ecuador Litigation (2006)
Company: Chevron Final Vote: 9% Year: 2006 …
Pfizer – Price Restraint/Access and Affordability (2005 – 2006)
Increasing Access to Pfizer Products RESOLVED: Shareholders request the Board of Directors report by September 2006 on measures Pfizer is taking to contain the price increases of its most-prescribed drugs to levels equal to or below the annual rate of inflation. SUPPORTING STATEMENT: Enacting this proposal will align our company with its previously stated practice on prescription drug price increases. Access to pharmaceutical products is essential for adequate health care for all Americans; we believe that restraining price increases is an effective way to expand access to pharmaceutical products. In 2002, Pfizer stated: “Over the past decade, after accounting for …
General Electric – Report on Meeting Public Interest Broadcasting Obligations (2004 – 2005)
2004-2005 Final Vote: Omitted …
Pfizer – Price Restraint/Access and Affordability (2004 – 2005)
2004-2005 Final Vote: 10.2% …
ChevronTexaco – Cleanup of Toxic Legacy in Ecuador (2003 – 2004)
Company: ChevronTexaco Final Vote: 9% Year: 2003-2004 …
Time Warner – Media Public Interest Obligations (2003 – 2004)
2003-2004 Final Vote: Withdrawn …
Recent Comments